Arecor Therapeutics announced today that it signed a co-development with Sequel Med Tech to pair their diabetes offerings.
Biolinq announced today that it received FDA de novo clearance for its lead product, the Biolinq Shine wearable biosensor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback